Protagenic Therapeutics I...

NASDAQ: PTIX · Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT

Protagenic Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.53M -5M -3.56M -4.52M
Depreciation & Amortization
50.29K 28.22K 30.00 427.14K
Stock-Based Compensation
923.14K 666.83K 864.68K 1.52M
Other Working Capital
467.54K -87.09K 631.73K -480.51K
Other Non-Cash Items
-132.14K 716.09K 156.85K 345.95K
Deferred Income Tax
n/a n/a n/a -427.14K
Change in Working Capital
467.54K -114.41K 540.13K -140.39K
Operating Cash Flow
-4.22M -3.7M -1.99M -2.8M
Capital Expenditures
n/a -149.78K -1.8K n/a
Cash Acquisitions
n/a n/a 46.05K n/a
Purchase of Investments
-297.12K -2.76M -34.12K -10.4M
Sales Maturities Of Investments
3.05M 7.69M 1.63M 485.95K
Other Investing Acitivies
51.73K n/a -46.05K -9.91K
Investing Cash Flow
2.8M 4.78M 1.6M -9.91M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 869.63K
Financial Cash Flow
1.96M n/a n/a 12.58M
Net Cash Flow
550.58K 1.07M -325.98K -129.92K
Free Cash Flow
-4.22M -3.85M -2M -2.8M